During the past decade, Leipzig Heart Institute GmbH conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Leipzig Heart Institute GmbH" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "C. R. Bard" with 1 trials sponsored, "IHF GmbH - Institut für Herzinfarktforschung" with 1 trials sponsored, "Keystone Heart" with 1 trials sponsored and "LMU Klinikum" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Leipzig Heart Institute GmbH" #1 collaborator was "Apollo Hospitals Enterprise Limited" with 1 trials as a collaborator, "Carolinas Medical Center" with 1 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator, "Far Eastern Memorial Hospital" with 1 trials as a collaborator and "Fortis Escorts Heart Institute" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Leipzig Heart Institute GmbH" are "Persistent Atrial Fibrillation" (3 trials), "Aortic Valve Stenosis" (2 trials), "Atrial Fibrillation" (1 trials), "Autonomic Nervous System Diseases" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Leipzig Heart Institute GmbH" in a lesser frequency.

Most popular intervention types in "Leipzig Heart Institute GmbH" are "Device" (7 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "FIRM-Guided Procedure and PVI" (2 trials), "CardioMEMSTM HF sensor - pulmonary artery pressure measurement" (1 trials), "Contemporary Valves (Sapien THV Series and Evolut THV Series)" (1 trials), "Conventional CABG" (1 trials) and "Embolic Protection Device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Leipzig Heart Institute GmbH" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Leipzig Heart Institute GmbH". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Leipzig Heart Institute GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Leipzig Heart Institute GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".